Enrolment criteria for the post-treatment study population.

<p><a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001756#pntd-0001756-g002" target="_blank">Figure 2</a> describes enrolment criteria for IS<i>2404</i> PCR confirmed BUD patients with incomplete wound healing (collection of swab samples feasible) who presented at Agogo Presbyterian Hospital, Ghana (<i>n</i> = 7), following completion of 56 doses of rifampicin and streptomycin administered within eight weeks. None of the eligible study participants was excluded.</p>




CC BY 4.0